NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
27/12/2024
Voltar para busca
Dado oficial do USPTO
SHIFT HEALTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SHIFT HEALTH
ST13
US500000086550934Classe
35, 36, 41
Pedido
86550934
Registro
5570901
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
21/01/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 41
Data de depósito
02/03/2015
Data de registro
25/09/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/12/2024
Última transação
21/01/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Primeiro uso
18/05/2015
Primeiro uso no comércio
18/05/2015
Código do desenho
4
Tipo de titular
03
Localização do titular
Toronto, Ontario, CA
Examinador
BHUPATHI, TARA
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SHI Consulting Inc.
Representantes
Otto O. Lee INTELLECTUAL PROPERTY LAW GROUP LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 41
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business management consultationadvising clients in the health and life sciences industries about corporate strategy developmentinvestment in and planning for research and developmentproduct and program portfolio managementstrategic planning for products and programsidentification and evaluation of strategic and commercial opportunitiescreation and management of partnerships and alliancesorganizational and operational design and managementcompany creation and managementinvestment attractioninfrastructure and site planningeconomic developmentassessment and improvement of organization performancebusiness related policy areasmarketingmanpower developmentmanagement of information and information technologybuilding academic and research capacityadvancing sustainable health innovationnavigating the innovation pathwayestablishing partnerships between public and private organizationsrisk planning for product developmentcreating medical affairs strategiesmarket researchmarket assessmentengagement of stakeholders in strategic planning
Classe 36
Financial analysis and consultation in the nature of assisting clients in the health and life sciences industries with financial and strategic initiativesfinancial restructuringvalue-based managementexecutive compensation designvaluation of unusual situationsprivatizationmergersacquisitionsalliances and joint venturestakeover defenseasset optionsrisk management
Classe 41
Educational services in the nature of conducting seminarsworkshopsconferences in the field of business management in the health and life sciences industries
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
27/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/12/2024
E815
TEAS SECTION 8 & 15 RECEIVED
26/07/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
25/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
25/09/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21/08/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
18/08/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
13/08/2018
IUAF
USE AMENDMENT FILED
10/08/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/08/2018
EISU
TEAS STATEMENT OF USE RECEIVED
10/08/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/08/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/08/2018
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
28/06/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22/05/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/03/2018
PUBO
PUBLISHED FOR OPPOSITION
27/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/02/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/02/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
16/02/2018
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
19/01/2018
GNSI
INQUIRY TO SUSPENSION E-MAILED
19/01/2018
CNSI
SUSPENSION INQUIRY WRITTEN
19/01/2018
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
17/01/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/07/2017
GNSL
LETTER OF SUSPENSION E-MAILED
16/07/2017
CNSL
SUSPENSION LETTER WRITTEN
16/07/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
13/07/2017
ALIE
ASSIGNED TO LIE
10/07/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
28/12/2016
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
23/06/2016
ALIE
ASSIGNED TO LIE
23/06/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/12/2015
GNSL
LETTER OF SUSPENSION E-MAILED
08/12/2015
CNSL
SUSPENSION LETTER WRITTEN
08/12/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/11/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/11/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/06/2015
GNRT
NON-FINAL ACTION E-MAILED
12/06/2015
CNRT
NON-FINAL ACTION WRITTEN
12/06/2015
DOCK
ASSIGNED TO EXAMINER
05/06/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/03/2015
NWAP
NEW APPLICATION ENTERED
05/03/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SHIFT HEALTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.